Mesa Laboratories Inc (MLAB)
Profitability ratios
Return on sales
| Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | |
|---|---|---|---|---|---|
| Gross profit margin | 61.64% | 61.02% | 59.18% | 64.97% | 55.54% |
| Operating profit margin | -125.85% | 1.52% | 2.55% | 9.23% | 6.73% |
| Pretax margin | -127.50% | -0.18% | 1.94% | 1.72% | 2.92% |
| Net profit margin | -117.60% | 0.42% | 1.01% | 2.44% | 1.15% |
Mesa Laboratories Inc's profitability ratios depict fluctuations over the past five years. The gross profit margin has shown a generally increasing trend, indicating the company's ability to control production costs and generate profits from sales. However, the operating profit margin has been more volatile, with a significant decline in the most recent year, possibly due to increased operating expenses relative to revenue.
The pretax margin and net profit margin have also experienced fluctuations, with both ratios showing a sharp decline in the latest year, reflecting challenges in generating profits before and after accounting for taxes. The negative values for the operating and pretax margins in the most recent year suggest that the company may be experiencing significant financial difficulties or one-time costs impacting profitability.
Overall, Mesa Laboratories Inc's profitability ratios indicate a mixed performance, with room for improvement in managing operating expenses and enhancing overall profitability to ensure sustainable financial health in the future.
Return on investment
| Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -60.89% | 0.50% | 0.66% | 2.05% | 1.94% |
| Return on assets (ROA) | -56.90% | 0.14% | 0.26% | 0.54% | 0.33% |
| Return on total capital | -85.27% | 0.78% | 1.32% | 1.87% | 2.20% |
| Return on equity (ROE) | -174.87% | 0.24% | 0.48% | 0.81% | 0.61% |
Mesa Laboratories Inc's profitability ratios show a fluctuating trend over the five-year period from 2020 to 2024. The operating return on assets (Operating ROA) declined significantly from 2.05% in 2021 to -60.89% in 2024, indicating a sharp deterioration in the company's ability to generate operating profits from its assets.
Similarly, the return on assets (ROA) also exhibited a downward trend, decreasing from 0.54% in 2021 to -56.90% in 2024. This suggests that Mesa Laboratories Inc's overall profitability in relation to its total assets worsened over the years.
The return on total capital experienced a substantial decline from 2.20% in 2020 to -85.27% in 2024, indicating a significant decrease in the company's ability to generate returns from both equity and debt capital employed.
Furthermore, the return on equity (ROE) plummeted from 0.81% in 2021 to -174.87% in 2024, reflecting a drastic decline in the company's ability to generate profits for its shareholders.
Overall, Mesa Laboratories Inc's profitability ratios demonstrate a concerning trend of decreasing profitability and efficiency in utilizing its assets and capital over the five-year period. Investors and stakeholders may need to closely monitor the company's performance and management strategies to address these profitability challenges.